I'm admittedly and happily biased but there is transparent and palpable excitement about all 5 ongoing clinical trials and, as it was explained and then reiterated, there will be copious amounts of trial readout data throughout the duration of 2014. Not too long ago I was lucky to be part of an enterprise with that kind of drive and laser liker focus and the results were stunning until some short termers got a hold of the control room and messed it up for everyone. But I digress.
My short take on it is that barring some unforeseable event setting it back, next year is going to be a watersshed year for the company's science and technology and what will be accomplished in the war on the big C.
There are not so many chances when the good of the hart and the purse are in the same place.